FDA rejects Disc's rare disease drug despite commissioner's voucher Read more
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments Read more
After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio Read more
March 5, 2025 @ 8:30 am

We are pleased to announce the next OBN C-Suite Breakfast Discussion, hosted by New England Biolabs Lyophilization Sciences at their new Milton Park site, Oxfordshire, on 5 March. This exclusive event will focus on how UK-based R&D SMEs in the life sciences sector can “Penetrate the US Market.” Keynote speakers include Laurie Spicer, Director of US Expansion at Foothold America, and Barney Balmforth, Co-Founder & CEO of Biofidelity. The discussion will explore key topics such as understanding the US healthcare sector, validating technologies, and developing effective partnering strategies to support successful growth.
The event will also feature a moderated round-table discussion for senior leaders in life sciences. This event is designed to foster high-level discussions, offering valuable thought leadership and practical insights for driving growth.